| 2223. Evaluation of the Microbiology and Clinical Outcomes of Spontaneous Bacterial Peritonitis (SBP) within a US Academic Health System P Chris Parish, AD Taylor, TJ Stone, V Luther, C Ohl, JR Beardsley Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 1845, 2023 | | 2023 |
| 182. Piperacillin/tazobactam (P/T) versus meropenem (Mero) for treatment of extended-spectrum beta-lactamase (ESBL)-producing E. coli and K. pneumoniae bloodstream infections … AL Cox, JR Beardsley, JC Williamson, TJ Stone, ME DeWitt, E Palavecino, ... Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 255, 2023 | | 2023 |
| Analysis of infections among patients with historical culture positive for extended-spectrum beta-lactamase (ESBL)–producing Escherichia coli or Klebsiella pneumoniae: Is ESBL … TJ Stone, M DeWitt, JW Johnson, JR Beardsley, I Munawar, E Palavecino, ... Antimicrobial Stewardship & Healthcare Epidemiology 3 (1), e47, 2023 | 3 | 2023 |
| Clinical impact of a multiplex rapid diagnostic pneumonia panel in critically ill patients JN Esplund, AD Taylor, TJ Stone, EL Palavecino, A Kilic, VP Luther, ... Antimicrobial Stewardship & Healthcare Epidemiology 3 (1), e5, 2023 | 8 | 2023 |
| 184. Impact of the BioFire® FilmArray® Blood Culture Identification 2 Panel on Antimicrobial Treatment of Enterobacterales Blood Stream Infections A Logan, J Beardsley, AD Taylor, JC Williamson, E Palavecino, V Luther, ... Open Forum Infectious Diseases 9 (Supplement_2), ofac492. 262, 2022 | | 2022 |
| 877. Synovial Fluid Testing Using the BioFire® Joint Infection (JI) Panel Potentially Decreases Time to Antibiotic Optimization for Acute Joint Infections B Whitt, A Kilic, E Palavecino, J Beardsley, C Ohl, T Stone, AD Taylor, ... Open Forum Infectious Diseases 9 (Supplement_2), ofac492. 070, 2022 | | 2022 |
| 333. Clinical Impact of a Multiplex Rapid Diagnostic Panel in Critically Ill Patients J Esplund, AD Taylor, T Stone, E Palavecino, A Kilic, V Luther, ... Open Forum Infectious Diseases 9 (Supplement_2), ofac492. 411, 2022 | | 2022 |
| Treatment of Candida nivariensis Blood Stream Infection With Oral Isavuconazole O Randazza, K Erickson, T Denmeade, V Luther, E Palavecino, ... Cureus 14 (12), 2022 | 1 | 2022 |
| Evaluating the use of dalbavancin for off-label indications K Taylor, J Williamson, V Luther, T Stone, J Johnson, Z Gruss, ... Infectious Disease Reports 14 (2), 266-272, 2022 | 16 | 2022 |
| Inpatient antibiotic costs associated with switching from vancomycin to daptomycin for outpatient parenteral antibiotic therapy J Beardsley, S Patel, C Cook, B Pierce, J Johnson, C Ohl, V Luther Hospital Pharmacy 57 (1), 17-19, 2022 | 1 | 2022 |
| Evaluation of the potential impact of a multiplex rapid diagnostic panel in critically ill patients with hospital-acquired pneumonia BJ Erich, A Kilic, E Palavecino, J Williamson, J Johnson, C Ohl, V Luther, ... Cureus 14 (1), 2022 | 11 | 2022 |
| A comparison of active versus passive methods of responding to rapid diagnostic blood culture results EL Chandler, KL Wallace, E Palavecino, JR Beardsley, JW Johnson, ... Antimicrobial Stewardship & Healthcare Epidemiology 2 (1), e75, 2022 | 2 | 2022 |
| Sustained impact of an antibiotic stewardship initiative targeting asymptomatic bacteriuria and pyuria in the emergency department MC Cash, G Hile, J Johnson, T Stone, J Smith, C Ohl, V Luther, ... Antimicrobial Stewardship & Healthcare Epidemiology 2 (1), e148, 2022 | 6 | 2022 |
| 1032. Evaluation of a Multiplex Rapid Diagnostic Panel in Respiratory Specimens from Critically Ill Patients with Hospital-Acquired Pneumonia BJ Erich, A Kilic, E Palavecino, J Williamson, J Johnson, C Ohl, V Luther, ... Open Forum Infectious Diseases 8 (Supplement_1), S606-S607, 2021 | | 2021 |
| 614. Evaluating the Use of Dalbavancin for Off-Label Indications K Taylor, J Williamson, T Stone, J Johnson, Z Gruss, V Luther, ... Open Forum Infectious Diseases 8 (Suppl 1), 410, 2021 | | 2021 |
| 51. Sustained Impact of an Antimicrobial Stewardship (AS) Initiative Targeting Asymptomatic Bacteriuria and Pyuria in the Emergency Department (ED) MC Cash, G Hile, J Johnson, T Stone, V Luther, C Ohl, J Beardsley Open Forum Infectious Diseases 8 (Suppl 1), S145, 2021 | 1 | 2021 |
| Impact of an interprofessional collaborative quality improvement initiative to decrease inappropriate thyroid function testing AB Bradshaw, AK Bonnecaze, CA Burns, JR Beardsley Hospital Pharmacy 56 (5), 481-485, 2021 | 1 | 2021 |
| Multicenter point prevalence evaluation of the utilization and safety of drug therapies for COVID-19 at the onset of the pandemic timeline in the United States NJ Rhodes, A Dairem, WJ Moore, A Shah, MJ Postelnick, ME Badowski, ... American Journal of Health-System Pharmacy 78 (7), 568-577, 2021 | 6 | 2021 |
| 838. Drivers of empiric carbapenem use: How important is history of extended-spectrum beta-lactamase (ESBL) infection? TJ Stone, J Beardsley, J Johnson, C Ohl, C Ohl, V Luther, E Palavecino, ... Open Forum Infectious Diseases 7 (Supplement_1), S460-S460, 2020 | | 2020 |
| A Self-Reflection Stewardship Workshop Improves Resident Physician Understanding of Ambulatory Antibiotic Stewardship J Nasim, C Ohl, S Hernandez, J Williamson, J Beardsley, J Johnson, ... Infection Control & Hospital Epidemiology 41 (S1), s103-s103, 2020 | | 2020 |
